Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 5/20 | 0.45 |
| ▸ | DPP4 | P27487 | 5/20 | 0.45 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.44 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.44 |
| ▸ | DHODH | Q02127 | 2/20 | 0.34 |
| ▸ | BRD4 | O60885 | 2/20 | 0.33 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.32 |
| ▸ | NTRK3 | Q16288 | 1/20 | 0.32 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24011908 | 0.94 | DPP4 (0.42) | ANPEPDPP4NR1H2NR1H3DHODH | |
| SCHEMBL29357723 | 0.93 | ANPEP (0.49) | ANPEPDPP4NR1H2NR1H3BRD4 | |
| SCHEMBL902459 | 0.93 | ANPEP (0.49) | ANPEPDPP4NR1H2NR1H3BRD4 | |
| SCHEMBL4582292 | 0.92 | ANPEP (0.41) | ANPEPDPP4NR1H2NR1H3DHODH | |
| SCHEMBL24011832 | 0.90 | ANPEP (0.46) | ANPEPDPP4NR1H2NR1H3LMNA | |
| SCHEMBL24012211 | 0.90 | ANPEP (0.46) | ANPEPDPP4NR1H2NR1H3BRD4 | |
| SCHEMBL19525798 | 0.89 | ANPEP (0.45) | ANPEPDPP4NR1H2NR1H3DHODH | |
| SCHEMBL11954355 | 0.88 | ANPEP (0.47) | ANPEPDPP4NR1H2NR1H3 | |
| SCHEMBL14003753 | 0.88 | ANPEP (0.44) | ANPEPDPP4NR1H2NR1H3MAPT | |
| SCHEMBL20130869 | 0.88 | DPP4 (0.44) | ANPEPDPP4NR1H2NR1H3BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210351356-A1 | IMIDE DERIVATIVE, LUMINESCENT COMPOSITION CONTAINING SAME, LUMINOUS THIN FILM, AND LUMINOUS PARTICLES | Konica Minolta, Inc. (JP) | 2021-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210351356-A1 | IMIDE DERIVATIVE, LUMINESCENT COMPOSITION CONTAINING SAME, LUMINOUS THIN FILM, AND LUMINOUS PARTICLES | IGF1R, IK, BMI1 | ANPEP 4805/4885DPP4 4366/4885NR1H2 1914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.